Follow on Google News News By Tag * Clinical Data Management * Biotech * Pharma * Clinical Trials * Cro * Scdm * China * India * Asia Clinical Research * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | SCDM Leader Selected as Keynote for Clinical Trials Asia EventPast chair will address global audience at Asia-Pacific conference
Talley’s selection emphasizes SCDM’s role as worldwide leader for quality data in clinical trials. “It is SCDM’s mission to support the clinical data management profession globally and meet the needs for training, best practices and certification,” In addition to the keynote, Talley will also participate on a panel discussing North American and European perspectives on data management. There is a major need for medications and therapies to meet the medical needs of the Asia-Pacific region, which is home to more than 45 percent of the world’s population. According to Talley, clinical trials conducted in Asia can yield information to help prevent mega illnesses, improve preventive care, predict which treatments have higher likelihood of success, reduce mortality rates and create a healthcare environment that is based on data, outcomes and best practices employed in other countries. Data Collection and Management in Clinical Trials Asia 2010 is produced by the International Quality & Productivity Center. The two-day conference will be held November 24-25 in Beijing. The Society for Clinical Data Management is a nonprofit professional organization dedicated to promoting excellence in clinical data management through professional development, education and certification. Established in 1994, SCDM has more than 2,600 members with an interest in advancing data management practices. For additional information, please visit http://www.scdm.org. # # # The Society for Clinical Data Management is a nonprofit professional organization dedicated to promoting excellence in clinical data management through professional development, education and certification. End
Account Email Address Disclaimer Report Abuse
|
|